AMGN has been in the news 375% more than usual
Mar 10, 2026, 2:32 PM
-6.84%
What does AMGN do
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGN has been in the news recently: Amgen (NASDAQ:AMGN) has been evaluated by fifteen analysts over the past three months, resulting in a mix of positive and negative outlooks. The article also highlights AbbVie's record revenue of $61.2 billion in 2025, indicating strong growth despite the patent expiration of its drug Humira.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.